ADVFN
Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

U.S. Stocks Move Mostly Higher As Day Progresses, Post Strong Weekly Gains

Latest News
May 16 2025 12:42PM

After initially showing a lack of direction, stocks moved mostly higher over the course of the trading session on Friday. The major averages all climbed firmly into positive territory after closing mixed for two straight sessions.

The major averages ended the day near their highs of the session. The Dow advanced 331.99 points or 0.8 percent to 42,654.74, the S&P 500 (SPI:SP500) climbed 41.45 points or 0.7 percent to 5,958.38 and the Nasdaq rose 98.78 points or 0.5 percent to 19,211.10.

For the week, the tech-heavy Nasdaq soared by 7.2 percent, the S&P 500 spiked by 5.3 percent and the Dow surged by 3.4 percent.

Stocks continued to benefit from recent upward momentum, which has propelled the major averages to their best closing levels in over two months.

Monday’s news of a U.S.-China trade deal temporarily slashing steep tariffs on each other’s goods generated considerable buying interest that has carried over throughout much of the week.

While uncertainty remains about the U.S. and its trade partners reaching deals that permanently lower tariffs, traders have continued to express optimism.

Meanwhile, traders largely shrugged off preliminary data from the University of Michigan showing consumer sentiment in the U.S. has unexpectedly continued to deteriorate in the month of May.

The University of Michigan said its consumer sentiment index dipped to 50.8 in May after slumping to 52.2 in April. Economists had expected the index to inch up to 53.4.

With the unexpected decrease, the consumer sentiment index has fallen to its lowest level since hitting 50.0 in June 2022.

The report also said year-ahead inflation expectations surged to 7.3 percent in May from 6.5 percent in April, reaching the highest level since a matching figure in November 1981.

Sector News

Biotechnology stocks moved sharply higher over the course of the session, driving the NYSE Arca Biotechnology Index up by 2.5 percent.

Significant strength also emerged among healthcare stocks, as reflected by the 1.9 percent gain posted by the Dow Jones U.S. Healthcare Index.

Utilities, housing and pharmaceutical stocks also saw notable strength on the day, moving higher along with most of the other major sectors.

Other Markets

In overseas trading, stock markets across the Asia-Pacific region turned in a mixed performance on Friday. China’s Shanghai Composite Index fell by 0.4 percent and Japan’s Nikkei 225 Index closed just below the unchanged line, while Australia’s S&P/ASX 200 Index advanced by 0.6 percent.

Meanwhile, the major European markets all moved to the upside on the day. While the U.K.’s FTSE 100 Index climbed by 0.6 percent, the French CAC 40 Index and the German DAX Index rose by 0.4 percent and 0.3 percent, respectively.

In the bond market, treasuries gave back ground after an early advance but still closed modestly higher. As a result, the yield on the benchmark ten-year notes, which moves opposite of its price, edged down 1.4 basis points to 4.441 percent.

Looking Ahead

Following a very busy week on the U.S. economic front, the economic calendar for next week is relatively quiet, although reports on weekly jobless claims and new and existing home sales may still attract attention along with remarks by several Federal Reserve officials.

SOURCE: RTTNEWS

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.
Some portions of this content may have been generated or assisted by artificial intelligence (AI) tools and been reviewed for accuracy and quality by our editorial team.

Top Stories